Patent · US Active

Binding molecule specific for LIF and use thereof

US12281168B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

JACOBIO PHARMACEUTICALS CO., LTD. · CN

Inventors

Qinghao LIU · Beijing, CN
Jun TAO · Beijing, CN
Wenlai Zhou · Cambridge, US
Shanshan He · North Bethesda, US
Haiyan Yang · 安丰镇, CN
Hongling WANG · Shanghai, CN
Guiqun YANG · Beijing, CN

Key dates

Filing date	Aug 20, 2021
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Aug 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a binding molecule specific for LIF and use thereof. Specifically, provided is an isolated antibody or an antigen-binding fragment thereof that binds to LIF and inhibits the activity of LIF. Also provided are uses of the isolated antibody or the antigen-binding fragment thereof in treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.